Berlinger Special AG: Uniform Security Standard for Doping Control Kits

Food and Healthcare Press Releases Monday February 5, 2018 12:40
GANTERSCHWIL, Switzerland--5 Feb--PRNewswire/

The BEREG-KITs preferred by the International Olympic Committee (IOC) can be used throughout the coming 2018 Olympic Winter Games in PyeongChang. Their manufacturer Berlinger Special AG is also adding further security features to the product to enable any counterfeit kits to be clearly identified as such. Berlinger Special AG will moreover be supplying only this new "Olympic" version of the BEREG-KIT with its additional anti-counterfeit features to other doping control organizations and sports federations from now on. So provided these kits are employed consistently for such purposes, a new uniform product can now be used for all doping controls.

(Photo: https://mma.prnewswire.com/media/637152/BEREG_KIT.jpg )
(Photo: https://mma.prnewswire.com/media/637150/BEREG_Production_Robots.jpg )

The IOC has decided to use not the "BEREG-KIT Geneva" but its predecessor, the "BEREG-KIT", which was supplied up until mid-September 2017, for the doping control activities at the coming 2018 Olympic Winter Games in PyeongChang, South Korea. This is because both the IOC and the World Anti-Doping Agency (WADA) see a risk in the handling procedure to close the BEREG-KIT Geneva container.

Berlinger Special AG has taken full account of the IOC's decision and the associated WADA recommendations, and is now focusing fully on producing this predecessor BEREG-KIT. The company will be able to provide all the BEREG-KITs required to meet the Olympic Winter Games' needs, and is in close contact with the event's organizers. Berlinger Special AG will also be putting all its production capacities into meeting the demand for these BEREG-KITs from other federations, organizations and customers.

Counterfeits always detectable

On WADA's recommendation, in resuming its production of the BEREG-KIT, Berlinger Special AG will also take the opportunity to introduce additional security features that will enable any counterfeit kits to be clearly identified as such. These security features, which take the form of complex identification elements, will provide additional protection for doping samples while not affecting either the nature of the BEREG-KIT containers or their closure technology. The type of kit desired by the IOC for the Games doping controls will thus incorporate a further set of security features.

A uniform solution for all sport

To avoid any market confusion and to focus all its resources on the production required, Berlinger Special AG has decided to only produce and supply this predecessor BEREG-KIT at the present time. This means that any Berlinger Special AG customers who currently have orders outstanding for the BEREG-KIT Geneva will now be supplied with the predecessor BEREG-KIT instead. Berlinger Special AG will also readily replace any customers' existing stocks of the BEREG-KIT Geneva with the predecessor BEREG-KIT. This will enable all doping controls to be conducted and all the resulting samples stored with a uniform technological solution.

Further information:
Berlinger Special AG
Media Relations
c/o. KMES Partner I KLAUS
Hans Klaus
Basteiplatz 7
CH-8001 Zurich
Phone: +41-43-544-1744
Email: office@kmespartner.com
Source: Berlinger Special AG

Latest Press Release

Michel Orsinger Assumes Role as Chairman of Limacorporate#s Advisory Board

LimaCorporate is pleased to announce that Michel Orsinger, Board Member of LimaCorporate's Advisory Board, will assume the role of Chairman of the Board. Michel joined the Advisory Board mid-2017 following a long and successful global career in...

Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer

Merck and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxorubicin (PLD), a type of chemotherapy, compared with PLD did not meet the...

APEC#s Rare Disease Action Plan Sets Precedent to Integrate Rare Disease Care by 2025

- Asia-Pacific Economic Cooperation (APEC) Life Sciences Innovation Forum (LSIF) Rare Disease Network comprises Rare Disease International, Queensland University of Technology and Shire (representing as industry co-chair). - Aims to define, diagnose and...

Grunenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US

Grunenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza(R) (8 % capsaicin) for...

Ascensia Diabetes Care Highlights the Support That Families Provide for People With Diabetes To Mark World Diabetes Day 2018

Today, Ascensia Diabetes Care, a global leading diabetes care company, launched their campaign for World Diabetes Day 2018 to celebrate the important role of families for people with diabetes. They are publishing 38 online artworks that tell the stories...

Related Topics